ARCHIVES

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

This article is from The Cancer Letter archive.

Vol. 35 No. 15 | April 17, 2009

Download PDF Visit The Full Archive

Related Articles

Diet & Nutrition Wins Ok To Use Program Grants

February 20, 1976

Studies Are Demonstrating Effectiveness of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

April 5, 1974

Funding Opportunities: NCI’s RAPID Program; RFA, Pas Avilable

May 14, 1999

Competing Core, P01 Grants Held To 7% Increases To Help Spread $$ Around

December 7, 1979

Senate Finance Reports A Reform Bill On Deadline

July 8, 1994

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

May 27, 2005